Lipocine's total assets for Q4 2025 were $17.01M, an increase of 5.80% from the previous quarter. LPCN total liabilities were $2.53M for the fiscal quarter, a 30.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.